A call for better reporting of trials using surrogate primary endpoints
- PMID: 35910671
- PMCID: PMC9323346
- DOI: 10.1002/trc2.12340
A call for better reporting of trials using surrogate primary endpoints
Conflict of interest statement
The authors declare no conflicts.
Figures

References
-
- Broich K. Outcome measures in clinical trials on medicinal products for the treatment of dementia: a European regulatory perspective. Int Psychogeriatr. 2007;19:509‐524. - PubMed
-
- Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69:89‐95. - PubMed
-
- Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996;125:605‐613. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous